Files

649914.pdf (755.29 KB)

Document type

Article

Version

Published version

Publication date

2015-02

Publication license

cc-by-nc (c) Darbà, Josep et al., 2015
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/96961

Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain

Journal Title

Authors

Director/Tutor

Additional contribution

Journal ISSN

Volume Title

Abstract

The objective of this study was to estimate the cost-effectiveness of denosumab for fracture prevention compared with no treatment, generic bisphosphonates, and strontium ranelate in a cohort of osteoporotic postmenopausal women in Spain.

Related resource

http://dx.doi.org/10.2147/CEOR.S78349

Subject

Anàlisi cost-benefici, Menopausa, Osteoporosi

Subject (English)

Cost effectiveness, Menopause, Osteoporosis

Citation

Collections

Articles publicats en revistes (Economia)

Citation

DARBÀ, Josep, et al. Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain. Clinicoeconomics and Outcomes Research. 2015. Vol. 2015, num. 7, pags. 105-117. ISSN 1178-6981. [consulted: 11 of October of 2026]. Available at: https://hdl.handle.net/2445/96961

Export metadata

JSON - METS

Share record